Holen Sie sich die Stockscreener-App
1.77
3.28%
-0.06
Handel nachbörslich:
1.80
0.03
+1.69%
Sutro Biopharma Inc Aktie (STRO) Neueste Nachrichten
Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Sold by Baillie Gifford & Co. - MarketBeat
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $11.13 Average PT from Analysts - MarketBeat
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by SG Americas Securities LLC - Defense World
Sutro Biopharma stock hits 52-week low at $1.67 amid market challenges - MSN
Shareholders in Sutro Biopharma (NASDAQ:STRO) have lost 86%, as stock drops 18% this past week - Simply Wall St
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Sutro Biopharma Inc (STRO) can make a big difference with a little luck - SETE News
Market Insights: Sutro Biopharma Inc (STRO)’s Notable Drop of -1.04, Closing at 1.90 - The Dwinnex
Have you been able to find a good deal on Sutro Biopharma Inc’s shares? - US Post News
We're Not Very Worried About Sutro Biopharma's (NASDAQ:STRO) Cash Burn Rate - Yahoo Finance
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Sutro Biopharma, Inc. (NASDAQ:STRO) Sees Large Growth in Short Interest - MarketBeat
Sutro Biopharma, Inc. (NASDAQ:STRO) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Consensus Recommendation of “Moderate Buy” from Brokerages - Defense World
Barclays PLC Acquires 216,757 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma stock hits 52-week low at $1.7 amid market challenges - Investing.com Canada
Sutro Biopharma (NASDAQ:STRO) versus Sorrento Therapeutics (OTCMKTS:SRNEQ) Head-To-Head Comparison - Defense World
Jane Street Group LLC Acquires 25,416 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
Sutro Biopharma and Boehringer Ingelheim BioXcellence™ collaboration: Established first-in-class cell-free capabilities at commercial scale - The Manila Times
Sutro Biopharma Achieves Breakthrough: Cell-Free Cancer Drug Production Scales to 4,500L - StockTitan
Great week for Sutro Biopharma, Inc. (NASDAQ:STRO) institutional investors after losing 42% over the previous year - Simply Wall St
Geode Capital Management LLC Has $6.43 Million Holdings in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma: I Don't Buy That Their Pipeline Is Worthless (NASDAQ:STRO) - Seeking Alpha
ADCs continue to sizzle, inspiring major deals - BioWorld Online
Sutro Biopharma, Inc. (NASDAQ:STRO) Shares Bought by Barclays PLC - Defense World
Short Interest in Sutro Biopharma, Inc. (NASDAQ:STRO) Expands By 19.4% - MarketBeat
State Street Corp Buys 81,855 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives $11.13 Consensus PT from Analysts - MarketBeat
Sutro Biopharma, Inc.'s (NASDAQ:STRO) latest 24% decline adds to one-year losses, institutional investors may consider drastic measures - Yahoo Finance
Charles Schwab Investment Management Inc. Acquires 35,167 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma stock hits 52-week low at $2.02 By Investing.com - Investing.com Canada
Fmr LLC Acquires 37,701 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma stock hits 52-week low at $2.02 - Investing.com
BNP Paribas Financial Markets Boosts Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
0.27%
3.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):